Proteins that specifically recognize cisplatin‐damaged DNA: a clue to anticancer activity of cisplatin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteins that specifically recognize cisplatin‐damaged DNA: a clue to anticancer activity of cisplatin

Published:1998-07 Issue:10 Volume:12 Page:791-799
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zlatanova Jordanka¹²,Yaneva Julia¹³,Leuba Sanford H.¹

Affiliation:

1. Department of Biochemistry and BiophysicsOregon State University Corvallis Oregon USA 97331–7305

2. Institute of GeneticsBulgarian Academy of Sciences 1113 Sofia Bulgaria

3. Institute of Molecular BiologyBulgarian Academy of Sciences 1113 Sofia Bulgaria

Funder

National Institutes of Health

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fasebj.12.10.791

Reference63 articles.

2. Cisplatin update;Muggia F. M.;Semin. Oncol.,1991

3. Salvage therapy for germ cell tumors;Einhorn L. H.;Semin. Oncol.,1994

4. Platinum compounds in cervical and endometrial cancers: focus on carboplatin;Muggia F. M.;Semin. Oncol.,1994

5. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methanolic Phoenix dactylifera L. Extract Ameliorates Cisplatin-Induced Hepatic Injury in Male Rats;Nutrients;2022-02-28

2. Homo and heterobimetallic palladium and platinum complexes bearing μ-diphosphane bridges involved in biological studies;European Journal of Medicinal Chemistry;2021-11

3. Cisplatin reacts with histone H1 and the adduct forms a ternary complex with DNA;Metallomics;2019-01-08

4. Engineered Polymeric Micelles for Combinational Oxidation Anticancer Therapy through Concurrent HO-1 Inhibition and ROS Generation;Biomacromolecules;2019-01-03

5. 1. CISPLATIN AND OXALIPLATIN: OUR CURRENT UNDERSTANDING OF THEIR ACTIONS;Metallo-Drugs: Development and Action of Anticancer Agents;2018-02-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3